TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07266285: BTM-3566 in Advanced Solid Tumors

Sponsor: Bantam Pharmaceuticals · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 30 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$10,053,120

Rescue Site Savings

+$6,628,776

Unlock Full NCT07266285 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07266285 Rescue Dossier →